Rivastigmine and Huperzine A as Treatments for Cocaine Dependence - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Beta test our new site.

(NLM Technical Bulletin)

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Rivastigmine and Huperzine A as Treatments for Cocaine Dependence

This study is currently recruiting participants.

Verified July 2012 by Baylor College of Medicine

Study NCT01030692 Information provided by Baylor College of Medicine

First Received on December 10, 2009. Last Updated on July 25, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Cocaine Dependence
Cocaine Addiction
Cocaine Abuse
Substance Abuse

Additional conditions recognized in this trial

Behavior, Addictive
Cocaine-Related Disorders
Substance-Related Disorders

More general conditions related to this trial

Compulsive Behavior
Impulsive Behavior
Mental Disorders

Interventions listed in this trial

Placebo
Rivastigmine 3 mg
Huperzine A 0.4 mg
Rivastigmine 6 mg
Huperzine A 0.8 mg

Additional drug interventions recognized in this trial

Cocaine
Huperzine A
Rivastigmine

Sponsors listed in this trial

Baylor College of Medicine
National Institute on Drug Abuse (NIDA)

Back to top of Main Content